MedPath

Doxycycline Plus Trimethoprim-sulfamethoxazole Versus Doxycycline Plus Rifampicin in Treatment of Brucellosis

Not Applicable
Recruiting
Conditions
Brucellosis
Registration Number
PACTR202210778524094
Lead Sponsor
Assiut University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

consecutive 100 patients with brucellosis who attend our outpatient clinic and inpatient ward will be enrolled in our study.

Exclusion Criteria

Complicated localized brucellosis (spondylitis, endocarditis, meningoencephalitis).
Age less than 18 years
Pregnancy
Receiving antibiotics for more than 1 week before enrolment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Successful Treatment ;Failure of therapy;Relapse
Secondary Outcome Measures
NameTimeMethod
Stoppage of treatment
© Copyright 2025. All Rights Reserved by MedPath